LEINER TO CONTINUE EXPANSION INTO OTC MARKET
This article was originally published in The Tan Sheet
Executive Summary
LEINER TO CONTINUE EXPANSION INTO OTC MARKET by leveraging its dominant position in the vitamin category, the company said in a May 5 filing with the Securities and Exchange Commission. Leiner Health Products Group "plans to continue to increase its sales of OTC pharmaceuticals to its existing vitamin product customers by building on its long-standing relationships and reputation for customer sales and marketing support, superior customer service, product quality and manufacturing expertise and flexibility," the filing states.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning